- Bio-Techne (TECH, Financial) announces a quarterly dividend of $0.08 per share, payable May 30, 2025.
- The company initiates a new $500 million share repurchase program effective May 8, 2025.
- Bio-Techne reported $1.2 billion in net sales for fiscal 2024.
Bio-Techne Corporation (NASDAQ: TECH) has unveiled two key financial strategies to enhance shareholder value. The Board of Directors declared a quarterly dividend of $0.08 per share, scheduled for payment on May 30, 2025, to shareholders recorded by May 19, 2025. This continued dividend reflects the company's steady commitment to returning value to its investors.
In addition to the dividend announcement, Bio-Techne's Board has approved a substantial $500 million share repurchase program set to commence on May 8, 2025. This new initiative replaces the prior buyback program and underscores the company's robust financial health and strategic focus on enhancing shareholder returns. The repurchase volume and timing will be influenced by factors such as market conditions and regulatory guidance.
Bio-Techne, a prominent player in the global life sciences sector, reported a strong revenue of approximately $1.2 billion for the fiscal year 2024. The company employs around 3,100 individuals worldwide, underlining its significant operational footprint and commitment to growth within the biotechnology industry.
